These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 27079892)
1. Editorial Commentary: miRNA a tiny genetic tool: Key to the puzzle of cardiovascular disease. Giridharan VV; Quevedo J; Krishnamurthy P; Thandavarayan RA Trends Cardiovasc Med; 2016 Jul; 26(5):420-2. PubMed ID: 27079892 [No Abstract] [Full Text] [Related]
2. microRNA therapeutics in cardiovascular disease models. Dangwal S; Thum T Annu Rev Pharmacol Toxicol; 2014; 54():185-203. PubMed ID: 24111539 [TBL] [Abstract][Full Text] [Related]
3. microRNAs in cardiovascular diseases: current knowledge and the road ahead. Condorelli G; Latronico MV; Cavarretta E J Am Coll Cardiol; 2014 Jun; 63(21):2177-87. PubMed ID: 24583309 [TBL] [Abstract][Full Text] [Related]
4. RNA Therapeutics for Treatment of Cardiovascular Diseases: Promises and Challenges. Lucas T; Dimmeler S Circ Res; 2016 Sep; 119(7):794-7. PubMed ID: 27635083 [No Abstract] [Full Text] [Related]
5. Single nucleotide polymorphisms of microRNA in cardiovascular diseases. Srivastava K; Tyagi K Clin Chim Acta; 2018 Mar; 478():101-110. PubMed ID: 29278723 [TBL] [Abstract][Full Text] [Related]
6. Platelet miRNAs and cardiovascular diseases. Fuentes E; Palomo I; Alarcón M Life Sci; 2015 Jul; 133():29-44. PubMed ID: 26003375 [TBL] [Abstract][Full Text] [Related]
7. miRNA-101: a potential target for tumor therapy. Gui T; Shen K Cancer Epidemiol; 2012 Dec; 36(6):537-40. PubMed ID: 22647681 [TBL] [Abstract][Full Text] [Related]
8. Targeting microRNAs for cardiovascular therapeutics in coronary artery disease. Hinkel R; Ng JK; Kupatt C Curr Opin Cardiol; 2014 Nov; 29(6):586-94. PubMed ID: 25159281 [TBL] [Abstract][Full Text] [Related]
9. Editorial: Therapeutic Potential of microRNAs in Vascular Disease. Maegdefessel L Curr Vasc Pharmacol; 2015; 13(3):277-9. PubMed ID: 26156263 [TBL] [Abstract][Full Text] [Related]
10. The advance of application for microRNAs in cancer gene therapy. Yang G; Yin B Biomed Pharmacother; 2014 Feb; 68(1):137-42. PubMed ID: 24183203 [TBL] [Abstract][Full Text] [Related]
11. Novel techniques and targets in cardiovascular microRNA research. Dangwal S; Bang C; Thum T Cardiovasc Res; 2012 Mar; 93(4):545-54. PubMed ID: 22072632 [TBL] [Abstract][Full Text] [Related]
14. Roles of miR-17-92 Cluster in Cardiovascular Development and Common Diseases. Gu H; Liu Z; Zhou L Biomed Res Int; 2017; 2017():9102909. PubMed ID: 28164128 [TBL] [Abstract][Full Text] [Related]
15. MicroRNAs as cancer players: potential clinical and biological effects. Bandres E; Agirre X; Ramirez N; Zarate R; Garcia-Foncillas J DNA Cell Biol; 2007 May; 26(5):273-82. PubMed ID: 17504023 [TBL] [Abstract][Full Text] [Related]
16. Current progress on microRNAs-based therapeutics in neurodegenerative diseases. Pereira P; Queiroz JA; Figueiras A; Sousa F Wiley Interdiscip Rev RNA; 2017 May; 8(3):. PubMed ID: 27882692 [TBL] [Abstract][Full Text] [Related]